Accellix: Greg Hamilton

Greg Hamilton has been appointed as CEO of flow cytometry company Accellix. Nir Nimrodi, the firm's former CEO, will remain chairman of the board. Hamilton was previously CEO and board member at io9, CEO and executive board member at Epigenomics, CEO and director at AltheaDx, chief operating officer and CFO at Enigma Diagnostics, VP of operations and finance at Third Wave Technologies, and VP of operations at Hologic. He holds an MBA from the University of Chicago and a BS in finance from Purdue University.